$57.35 -1.37 (%) AbbVie Inc - NYSE

Sep. 23, 2014 | 03:11 PM

Partner Headlines

  1. Stocks Lower In Afternoon Trading; CarMax Plunges

    IBD | Sep. 23, 2014 | 13:23PM EST
  2. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  3. Shares Feel The Squeeze Of Treasury's Inversion Rules

    IBD | Sep. 23, 2014 | 12:25PM EST
  4. Bank Of America Believes Anti-Inversion Rules Are Not A Deal-Breaker For AbbVie Inc

    Benzinga | Sep. 23, 2014 | 11:16AM EST
  5. Morning Market Losers

    Benzinga | Sep. 23, 2014 | 09:47AM EST
  6. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 23, 2014 | 08:20AM EST
  7. #PreMarket Primer: Tuesday, September 23: First Airstrikes In Syria Begin

    Benzinga | Sep. 23, 2014 | 07:28AM EST
  8. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga | Sep. 22, 2014 | 12:59PM EST
  9. Google Makes a Breakthrough in Life Science

    GuruFocus | Sep. 18, 2014 | 15:06PM EST
  10. Gilead Stock Is Falling On These Drug Setbacks

    IBD | Sep. 17, 2014 | 12:52PM EST
  11. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga | Sep. 17, 2014 | 11:45AM EST
  12. Gilead Up As Analyst Lifts Sovaldi Q3 Estimate

    IBD | Sep. 16, 2014 | 13:57PM EST
  13. Valeant, Allergan Settle Suit, Allow Shareholder Vote

    IBD | Sep. 16, 2014 | 11:36AM EST
  14. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  15. Corporate Tax Cuts Would Help Treasury And Investors

    IBD | Sep. 11, 2014 | 18:04PM EST
  16. US Stock Futures Drop Ahead Of Jobless Claims Report

    Benzinga | Sep. 11, 2014 | 07:18AM EST
  17. AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy Of HUMIRA In Patients With Hidradenitis Suppurativa, A Chronic Inflammatory Skin Disease

    Benzinga | Sep. 11, 2014 | 04:33AM EST
  18. Google Inc Expands Biotech Investment With Life Labs Buy

    Benzinga | Sep. 10, 2014 | 15:41PM EST
  19. Pharmacyclics Price Target Cut On Higher Spending

    IBD | Sep. 8, 2014 | 13:02PM EST
  20. Why Gilead Is Falling On Drugs For Developing Nations

    IBD | Sep. 5, 2014 | 15:15PM EST
  21. Infinity, AbbVie team on drug

    IBD | Sep. 3, 2014 | 18:36PM EST
  22. S&P 500 Struggles To Hold 2,000 As Commodities Rebound

    Benzinga | Sep. 3, 2014 | 17:01PM EST
  23. Midday Gainers From Wednesday, September 3

    Benzinga | Sep. 3, 2014 | 14:41PM EST
  24. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD | Sep. 3, 2014 | 13:20PM EST
  25. NASDAQ Tumbles 0.5%; Infinity Pharmaceuticals Jumps On Deal With AbbVie

    Benzinga | Sep. 3, 2014 | 13:01PM EST
  26. Markets Gain; Toll Brothers Profit Beats Estimates

    Benzinga | Sep. 3, 2014 | 11:22AM EST
  27. Benzinga's Volume Movers

    Benzinga | Sep. 3, 2014 | 10:27AM EST
  28. Morning Market Movers

    Benzinga | Sep. 3, 2014 | 09:43AM EST
  29. Stock Futures Up And Climbing; Baidu Heads China Stock Rally

    IBD | Sep. 3, 2014 | 09:08AM EST
  30. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 3, 2014 | 08:04AM EST
  31. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  32. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga | Aug. 27, 2014 | 20:45PM EST
  33. After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

    GuruFocus | Aug. 27, 2014 | 15:06PM EST
  34. Bristol-Myers Hepatitis C Therapy Approved in EU

    IBD | Aug. 27, 2014 | 12:03PM EST
  35. IRS, Eh? Tim Hortons Deal Could Lower Burger King's Tax Bill

    FoxBusiness | Aug. 25, 2014 | 14:10PM EST
  36. Why Burger King Isn't Like Walgreen In Tax Inversions

    IBD | Aug. 25, 2014 | 13:23PM EST
  37. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD | Aug. 15, 2014 | 18:10PM EST
  38. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD | Aug. 15, 2014 | 12:23PM EST
  39. 5 Companies That Have Moved Overseas For Lower Taxes

    Benzinga | Aug. 12, 2014 | 10:06AM EST
  40. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD | Aug. 8, 2014 | 16:45PM EST
  41. Markets Little Changed As Ukraine Uncertainty And Fears Persist

    Benzinga | Aug. 6, 2014 | 16:58PM EST
  42. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD | Aug. 6, 2014 | 10:15AM EST
  43. #PreMarket Primer: Wednesday, August 6: Sprint Prepares To Go It Alone

    Benzinga | Aug. 6, 2014 | 07:17AM EST
  44. Walgreen Seen Rejecting Tax Inversion Amid Pressure

    IBD | Aug. 5, 2014 | 15:26PM EST
  45. Walgreen Names New CFO Ahead of Possible Inversion

    IBD | Aug. 4, 2014 | 12:29PM EST
  46. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD | Aug. 4, 2014 | 10:56AM EST
  47. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD | Aug. 2, 2014 | 08:02AM EST
  48. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga | Aug. 1, 2014 | 15:21PM EST
  49. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD | Aug. 1, 2014 | 12:35PM EST
  50. The Stocks Already in Correction Mode

    FoxBusiness | Aug. 1, 2014 | 08:15AM EST
Trading Center